Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Julphar
Teva
Moodys
Cipla
Fish and Richardson
Mallinckrodt
Chinese Patent Office
Argus Health

Generated: January 20, 2019

DrugPatentWatch Database Preview

PYRIDOSTIGMINE BROMIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for pyridostigmine bromide and what is the scope of pyridostigmine bromide patent protection?

Pyridostigmine bromide is the generic ingredient in three branded drugs marketed by Valeant Pharm Intl, Sandoz Inc, Valeant Pharms, Valeant Pharms Llc, Alvogen Malta, Impax Labs Inc, Rising Pharms, Ani Pharms Inc, Apnar Pharma Lp, Impax Labs, Solvay, Us Army, and Zydus Pharms Usa Inc, and is included in fifteen NDAs. Additional information is available in the individual branded drug profile pages.

There are eleven drug master file entries for pyridostigmine bromide. Eleven suppliers are listed for this compound.

Pharmacology for PYRIDOSTIGMINE BROMIDE
Medical Subject Heading (MeSH) Categories for PYRIDOSTIGMINE BROMIDE

US Patents and Regulatory Information for PYRIDOSTIGMINE BROMIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 040512-001 Oct 8, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Valeant Pharms Llc MESTINON pyridostigmine bromide TABLET;ORAL 009829-002 Approved Prior to Jan 1, 1982 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Valeant Pharms MESTINON pyridostigmine bromide SYRUP;ORAL 015193-001 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Impax Labs PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 040502-001 Apr 24, 2003 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Solvay PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET;ORAL 089572-001 Nov 27, 1990 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Rising Pharms PYRIDOSTIGMINE BROMIDE pyridostigmine bromide TABLET, EXTENDED RELEASE;ORAL 205464-001 Aug 15, 2017 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Johnson and Johnson
Accenture
UBS
Queensland Health
Merck
Harvard Business School
AstraZeneca
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.